Skip to main content
. 2018 Oct 5;9(10):190. doi: 10.1038/s41424-018-0056-x

Table 1.

Comparison of baseline demographic, clinical and laboratory characteristics between survivors and non-survivors

Variable Total (n = 209) Survivors (n = 163) Non-survivors (n = 46) p value
Age (year) 40.2 ± 14.1 39.5 ± 13.6 42.8 ± 15.8 0.20
Male 124 (59) 99 (61) 25 (54) 0.4
Etiology 0.5
 Biliary 107 (51) 79 (49) 28 (61)
 Alcohol 50 (24) 39 (24) 11 (24)
 Idiopathic 33 (16) 26 (16) 7 (15)
 Others 19 (9) 19 (11) 0
Referred patient 144 (69) 101 (62) 43 (94) 0.001
Delay in presentation (days) 8 (0–90) 6 (0–90) 17 (2–90) 0.001
Intervention prior to referral (number of patients) 10 (7) 6 (6) 4 (9) 0.4
CCI> 2 24 (11) 11 (7) 13 (28) 0.001
Prophylactic antibiotic use 65 (31) 43 (26) 22 (48) 0.001
APACHE II at admission 6 (0–28) 6 (0–19) 11 (3–28) 0.001
Marshall score at admission 0 (0–7) 0 (0–5) 3 (0–7) 0.001
Modified CTSI 8 (0–10) 8 (0–10) 10 (4–10) 0.001
Necrosis 112 (54) 75 (46) 37 (80.5) 0.001
Persistent OF 81 (39) 39 (24) 42 (91) 0.001
Early OF 58 (28) 33 (20) 25 (54.3) 0.001
IPN 108 (52) 69 (42) 39 (85) 0.001
MDR organism 80 (38) 41 (25) 39 (85) 0.001
XDR organism 52 (25) 25 (15) 27 (59) 0.001
Fungal infection 27 (13) 14 (9) 13 (28) 0.001
Extra-pancreatic infection 29 (14) 17 (11) 12 (26) 0.01
Air in collection prior to interventiona 32 (24) 27 (30) 5 (12) 0.03
Need for any intervention 93 (45) 54 (33) 39 (85) 0.001
Surgical intervention 28 (13) 12 (7) 16 (35) 0.001
Walled off necrosisa 54 (41) 40 (44) 14 (34) 0.3
Duration of hospital stay (day) 14 (3–120) 12 (3–120) 27 (5–100) 0.001

Values as mean ± SD, median (range), and n (%) as appropriate

CCI Charlson co morbidity index, MDR multidrug resistant, OF organ failure, IPN infected pancreatic necrosis, CTSI CT severity index

aCollection present in 133 patients